» Articles » PMID: 33429859

Assessment of Lifestyle Factors Helps to Identify Liver Fibrosis Due to Non-Alcoholic Fatty Liver Disease in Obesity

Overview
Journal Nutrients
Date 2021 Jan 12
PMID 33429859
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Only some individuals with obesity develop liver fibrosis due to non-alcoholic fatty liver disease (NAFLD-fibrosis). We determined whether detailed assessment of lifestyle factors in addition to physical, biochemical and genetic factors helps in identification of these patients. A total of 100 patients with obesity (mean BMI 40.0 ± 0.6 kg/m) referred for bariatric surgery at the Helsinki University Hospital underwent a liver biopsy to evaluate liver histology. Physical activity was determined by accelerometer recordings and by the Modifiable Activity Questionnaire, diet by the FINRISK Food Frequency Questionnaire, and other lifestyle factors, such as sleep patterns and smoking, by face-to-face interviews. Physical and biochemical parameters and genetic risk score (GRS based on variants in , , and ) were measured. Of all participants 49% had NAFLD-fibrosis. Independent predictors of NAFLD-fibrosis were low moderate-to-vigorous physical activity, high red meat intake, low carbohydrate intake, smoking, HbA, triglycerides and GRS. A model including these factors (areas under the receiver operating characteristics curve (AUROC) 0.90 (95% CI 0.84-0.96)) identified NAFLD-fibrosis significantly more accurately than a model including all but lifestyle factors (AUROC 0.82 (95% CI 0.73-0.91)) or models including lifestyle, physical and biochemical, or genetic factors alone. Assessment of lifestyle parameters in addition to physical, biochemical and genetic factors helps to identify obese patients with NAFLD-fibrosis.

Citing Articles

Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy.

Xu J, Li Y, Feng Z, Chen H Cells. 2025; 14(3).

PMID: 39937012 PMC: 11816580. DOI: 10.3390/cells14030221.


Association between sleep duration and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis.

Pirahesh K, Zarrinnia A, Nikniaz L, Nikniaz Z Prev Med Rep. 2025; 50:102968.

PMID: 39897736 PMC: 11783128. DOI: 10.1016/j.pmedr.2025.102968.


Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of the Art Update.

Sookoian S, Rotman Y, Valenti L Clin Gastroenterol Hepatol. 2024; 22(11):2177-2187.e3.

PMID: 39094912 PMC: 11512675. DOI: 10.1016/j.cgh.2024.05.052.


High red meat consumption among PNPLA3 polymorphism carriers is associated with NAFLD in a multi-center cross-sectional study.

Alvares-da-Silva M, Ivancovsky-Wajcman D, Oliveira C, Rabie S, Longo L, Uribe-Cruz C Eur J Clin Nutr. 2024; 78(5):442-448.

PMID: 38403728 DOI: 10.1038/s41430-024-01416-w.


Controlled attenuation parameters to assess liver steatosis in obese patients with polycystic ovary syndrome.

Wang D, Nan N, Bing H, He B Front Endocrinol (Lausanne). 2023; 14:1241734.

PMID: 37720537 PMC: 10501797. DOI: 10.3389/fendo.2023.1241734.


References
1.
Ekstedt M, Hagstrom H, Nasr P, Fredrikson M, Stal P, Kechagias S . Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2014; 61(5):1547-54. DOI: 10.1002/hep.27368. View

2.
Thompson P, Buchner D, Pina I, Balady G, Williams M, Marcus B . Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition,.... Circulation. 2003; 107(24):3109-16. DOI: 10.1161/01.CIR.0000075572.40158.77. View

3.
Machado M, Marques-Vidal P, Cortez-Pinto H . Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol. 2006; 45(4):600-6. DOI: 10.1016/j.jhep.2006.06.013. View

4.
Shah A, Lydecker A, Murray K, Tetri B, Contos M, Sanyal A . Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009; 7(10):1104-12. PMC: 3079239. DOI: 10.1016/j.cgh.2009.05.033. View

5.
Angulo P, Kleiner D, Dam-Larsen S, Adams L, Bjornsson E, Charatcharoenwitthaya P . Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2015; 149(2):389-97.e10. PMC: 4516664. DOI: 10.1053/j.gastro.2015.04.043. View